Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mathew, J. T.
Right arrow Articles by Jacob, C. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathew, J. T.
Right arrow Articles by Jacob, C. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2003) 18: 164-171
© 2003 European Renal Association-European Dialysis and Transplant Association

Post-transplant hyperglycaemia: a study of risk factors

Jayant T. Mathew1, Madhumathi Rao1,, Victoria Job2, Selvakumar Ratnaswamy2 and Chakko K. Jacob1

1 Department of Nephrology and 2 Department of Biochemistry, Christian Medical College Hospital, Vellore, India

Background. Post-transplant diabetes mellitus (PTDM) has several identifiable pre- and post-transplant risk factors. The link to nutritional status pre-transplant has not been explored previously. This study was conducted to identify risk factors for the development of PTDM, with emphasis on pre-transplant nutritional status and glucose tolerance.

Methods. Non-diabetic adult end-stage renal failure patients awaiting renal transplantation were studied prospectively. Their nutritional status was assessed as body mass index (BMI), serum albumin, and the evolution of these parameters over time prior to transplantation. An oral glucose tolerance test (OGTT) was performed pre- and serially post-transplant until 6 months. Pre- and post-transplant risk factors such as age, nutritional status, glucose tolerance parameters and immunosuppression were related to the development of PTDM or impaired glucose tolerance (IGT) post-transplant.

Results. The mean age of 174 patients studied over a 2-year period was 32.9±9.7 years. The mean post-transplant follow-up was 25.6±12.8 months. The mean BMI at recruitment was 18.3±2.4 kg/m2. The rate of increase in BMI pre-transplant showed an inverse correlation with the baseline BMI (r=-0.34, P=0.000) and formed an independent marker of nutritional status. PTDM developed in 21.4% patients and 24.1% had IGT. On univariate and multivariate analyses, the factors significantly associated with the development of PTDM were greater age, more rapid increase in dry weight after starting haemodialysis (HD), elevated pre-transplant OGTT responses and cyclosporin (CsA) and prednisolone doses early post-transplant. Additionally, on multivariate analysis, higher CsA trough level >300 ng/ml at 3 months increased the risk for the development of PTDM. Of patients who developed PTDM, 57% had impairment of glucose tolerance pre-transplant (>140 mg/dl at 2 h). Patients with a 1-h glucose value greater than the 50th percentile on pre-transplant OGTT had a 3.9-fold greater risk for the development of PTDM (P=0.05, 95% CI=1.03–11.1). In those patients with higher 1-h glucose (>50th percentile) who also gained in dry weight rapidly pre-transplant, the risk increased to 5.3 (P=0.02). Of 76 patients with abnormal OGTT early post-transplant, only 68% continued to have PTDM or IGT post-transplant, the remainder reverting to normal glucose tolerance.

Conclusions. Persistent abnormal glucose tolerance after transplantation was seen in 45% of the patients. Pre-transplant factors including greater age, abnormal glucose tolerance parameters, and rapid gain in dry weight on HD, along with higher prednisolone and CsA doses early post-transplant were the important factors associated with the development of PTDM. Identification of patients with pre-transplant risks might allow modification of post-transplant immunosuppression with non-diabetogenic agents.

Keywords: body mass index; cyclosporin; malnutrition; oral glucose tolerance test; post-transplant diabetes mellitus; prednisolone

Correspondence and offprint requests to: Madhumathi Rao, Division of Nephrology (Tupper 225), New England Medical Center, Boston, MA 02111, USA. Email: haranrp{at}hotmail.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CJASNHome page
K. A. Armstrong, J. B. Prins, E. M. Beller, S. B. Campbell, C. M. Hawley, D. W. Johnson, and N. M. Isbel
Should an Oral Glucose Tolerance Test Be Performed Routinely in All Renal Transplant Recipients?
Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 100 - 108.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. Ponticelli
Renal transplantation 2004: where do we stand today?
Nephrol. Dial. Transplant., December 1, 2004; 19(12): 2937 - 2947.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.